OTCMKTS:NUGS Cannabis Strategic Ventures Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cannabis Strategic Ventures Please log in to your account or sign up in order to add this asset to your watchlist. $0.01 +0.00 (+1.48%) (As of 06/30/2022 12:00 AM ET) Add Compare Share Today's Range$0.01▼$0.0250-Day Range$0.01▼$0.0352-Week Range$0.01▼$0.08Volume467,451 shsAverage Volume1.27 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NUGS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannabis Strategic Ventures and its competitors with MarketBeat's FREE daily newsletter. Email Address NUGS Stock Forecast (MarketRank)Overall MarketRank™1.00 out of 5 starsAnalyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cannabis Strategic Ventures. Previous Next 5.0 Community Rank Outperform VotesCannabis Strategic Ventures has received 3 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCannabis Strategic Ventures has received 0 “underperform” votes. (Add your “underperform” vote.)Community SentimentCannabis Strategic Ventures has received 100.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cannabis Strategic Ventures and other stocks. Vote “Outperform” if you believe NUGS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NUGS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCannabis Strategic Ventures does not currently pay a dividend.Dividend GrowthCannabis Strategic Ventures does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cannabis Strategic Ventures insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here About Cannabis Strategic Ventures (OTCMKTS:NUGS)Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.Read More NUGS Stock News HeadlinesJuly 1, 2022 | msn.comDoes the FDA's Juul Ban Threaten Cannabis Stocks?June 30, 2022 | benzinga.comNew Restrictions On Synthetic Marijuana: Harm To The Cannabis Industry?June 30, 2022 | msn.comCannabis addiction risk higher in teenagers than adults, study suggestsJune 30, 2022 | msn.comNY Cannabis Advisory Board holds its first meetingJune 30, 2022 | apnews.comNY Cannabis Insider Announces Fall 2022 Lineup of EventsJune 30, 2022 | msn.comBreadth Of Rights And Social Justice In Nevada: CCB Approved Cannabis Consumption Lounge RegulationsJune 29, 2022 | msn.comPot lounge rules, regulations approved by Nevada Cannabis Compliance BoardJune 29, 2022 | msn.com1Phinest Cannabis Opens Flagship Tissue Culture And Nursery FacilityJune 27, 2022 | wsj.comCannabis Has Benefits, but Its Risks Are RealJune 27, 2022 | apnews.comNewLake Capital Partners to Participate in the Force for Knowledge Cannabis Symposium on June 29thJune 26, 2022 | msn.comREFILE-Cannabis use has risen with legalization and COVID lockdowns -U.N. reportJune 25, 2022 | msn.comNew England Cannabis Convention returns to the Green Mountain StateJune 24, 2022 | markets.businessinsider.comKhalifa Kush To Launch At Gage Cannabis Dispensaries In MichiganSee More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers-Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:NUGS CUSIPN/A CIK1290504 Webwww.cannabisstrategic.com Phone(310) 359-6860FaxN/AEmployees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Cannabis Strategic Ventures Frequently Asked Questions How has Cannabis Strategic Ventures' stock performed in 2022? Cannabis Strategic Ventures' stock was trading at $0.0232 at the beginning of the year. Since then, NUGS stock has decreased by 40.9% and is now trading at $0.0137. View the best growth stocks for 2022 here. Who are Cannabis Strategic Ventures' key executives? Cannabis Strategic Ventures' management team includes the following people: Mr. Simon Yu M.B.A., Chief Exec. Officer (Age 40)Paul Hutchin, PresMs. Arlene Guzman, VP of OperationsMr. John Vu, Legal CounselJ. Brown, Sec. and Director Who are some of Cannabis Strategic Ventures' key competitors? Some companies that are related to Cannabis Strategic Ventures include 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abattis Bioceuticals (ATT), Acreage (ACRHF), Acreage (ACRDF), AFT Pharmaceuticals (AFP), Agra Ventures (AGFAF), Agraflora Organics International (AGRA), Aleafia Health (ALEAF), American Green (ERBB), Ascend Wellness (AWWH), Australian Primary Hemp (APH), BellRock Brands (DXBRF) and Benchmark (BHCCF). View all of NUGS's competitors. What other stocks do shareholders of Cannabis Strategic Ventures own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabis Strategic Ventures investors own include Aphria (APHA), Annovis Bio (ANVS), Amex Exploration (AMX), Amyris (AMRS), (AMPE), (ALLIF), Aleafia Health (ALEAF), Aldeyra Therapeutics (ALDX), Agraflora Organics International (AGRA) and Acreage (ACRGF). What is Cannabis Strategic Ventures' stock symbol? Cannabis Strategic Ventures trades on the OTCMKTS under the ticker symbol "NUGS." How do I buy shares of Cannabis Strategic Ventures? Shares of NUGS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cannabis Strategic Ventures' stock price today? One share of NUGS stock can currently be purchased for approximately $0.01. How many employees does Cannabis Strategic Ventures have? Cannabis Strategic Ventures employs 30 workers across the globe. How can I contact Cannabis Strategic Ventures? Cannabis Strategic Ventures' mailing address is 833 S Spring St Ste 202, Los Angeles, California 90014-2964. The official website for Cannabis Strategic Ventures is www.cannabisstrategic.com. The company can be reached via phone at (310) 359-6860. This page (OTCMKTS:NUGS) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
